HF
ATHE

HRT Financial’s Alterity Therapeutics ATHE Stock Holding History

HRT Financial’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92K Buy
+17,292
New +$75.2K ﹤0.01% 3635
2022
Q3 		– Sell
-1,138
Closed -$6K – 2777
2022
Q2 		$6K Buy
+1,138
New +$8.07K ﹤0.01% 2723
2021
Q4 		– Sell
-1,061
Closed -$13K – 3159
2021
Q3 		$13K Sell
1,061
-1,738
-62% -$24.2K ﹤0.01% 3172
2021
Q2 		$36K Buy
+2,799
New +$37.9K ﹤0.01% 2699

Other funds holding ATHE

TLCM
Twin Lakes Capital Management Redwood Shores, California $262M AUM 60.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
PCA
Providence Capital Advisors Charlotte, North Carolina $660M AUM 17.81% 1-Year Est. Return

HRT Financial's ATHE Position: Q2 2026 in Review

HRT Financial opened a new position in Alterity Therapeutics (ATHE) in Q2 2026: 17,292 shares worth $92K. The stake represents ﹤0.01% of the portfolio and ranks #3635 among its holdings. This is a return to the name: HRT Financial previously reported a position in ATHE as recently as Q2 2022.

HRT Financial first reported a position in ATHE in Q2 2021 and has held it in 4 quarters since. 22 funds tracked by Wall St. Rank hold ATHE as of Q2 2026.

  • HRT Financial held 17,292 shares of Alterity Therapeutics worth $92K as of Q2 2026.
  • Alterity Therapeutics was a new HRT Financial position in Q2 2026.
  • Alterity Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3635 holding.
  • HRT Financial first reported a position in Alterity Therapeutics in Q2 2021 and has held it in 4 quarters since.
  • 22 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.